News & Analysis as of

MedPAC Congressional Investigations & Hearings Artificial Intelligence

Holland & Knight LLP

Holland & Knight Health Dose: March 10, 2026

Holland & Knight LLP on

No major healthcare legislation is currently scheduled for Senate floor consideration; healthcare policy activity is expected to remain concentrated at the committee level. Last week, the Senate Committee on Health,...more

Holland & Knight LLP

Holland & Knight Health Dose: March 3, 2026

Holland & Knight LLP on

U.S. Congress returns to session this week after the U.S. military launched strikes against Iran and defended against retaliatory actions against U.S. military personnel and presences across the Middle East. Both the U.S....more

Holland & Knight LLP

Holland & Knight Health Dose: January 13, 2026

Holland & Knight LLP on

The U.S. House of Representatives has passed a bill to extend the enhanced advanced premium tax credits (APTCs) for three years following a 230-196 vote, with 17 Republicans voting with Democrats to support its passage. The...more

Holland & Knight LLP

Holland & Knight Health Dose: April 8, 2025

Holland & Knight LLP on

Looking Ahead: House to Vote on Compromise Budget Resolution On the heels of the U.S. Senate's passage of a compromise budget resolution, the U.S. House of Representatives is expected to consider the budget resolution on the...more

Holland & Knight LLP

Holland & Knight Health Dose: March 5, 2024

Holland & Knight LLP on

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector. ...more

5 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide